Citigroup’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-37,657
| Closed | -$32.7K | – | 5047 |
|
|
2023
Q2 | $32.7K | Sell |
37,657
-1,008,500
| -96% | -$877K | ﹤0.01% | 4147 |
|
|
2023
Q1 | $731K | Hold |
1,046,157
| – | – | ﹤0.01% | 2251 |
|
|
2022
Q4 | $858K | Sell |
1,046,157
-615
| -0.1% | -$504 | ﹤0.01% | 2151 |
|
|
2022
Q3 | $1.09M | Sell |
1,046,772
-406
| -0% | -$422 | ﹤0.01% | 2042 |
|
|
2022
Q2 | $1.72M | Buy |
1,047,178
+1,044,658
| +41,455% | +$1.71M | ﹤0.01% | 1679 |
|
|
2022
Q1 | $7K | Sell |
2,520
-8,033
| -76% | -$22.3K | ﹤0.01% | 4915 |
|
|
2021
Q4 | $50K | Buy |
10,553
+4,071
| +63% | +$19.3K | ﹤0.01% | 4300 |
|
|
2021
Q3 | $49K | Sell |
6,482
-40,630
| -86% | -$307K | ﹤0.01% | 4002 |
|
|
2021
Q2 | $351K | Buy |
47,112
+29,864
| +173% | +$222K | ﹤0.01% | 3276 |
|
|
2021
Q1 | $135K | Sell |
17,248
-632
| -4% | -$4.95K | ﹤0.01% | 3569 |
|
|
2020
Q4 | $165K | Buy |
+17,880
| New | +$165K | ﹤0.01% | 3353 |
|
|
2020
Q1 | – | Sell |
-1,281
| Closed | -$2K | – | 5244 |
|
|
2019
Q4 | $2K | Buy |
1,281
+6
| +0.5% | +$9 | ﹤0.01% | 5008 |
|
|
2019
Q3 | $2K | Sell |
1,275
-428
| -25% | -$671 | ﹤0.01% | 4980 |
|
|
2019
Q2 | $5K | Sell |
1,703
-1,748
| -51% | -$5.13K | ﹤0.01% | 4897 |
|
|
2019
Q1 | $16K | Buy |
3,451
+1,067
| +45% | +$4.95K | ﹤0.01% | 4615 |
|
|
2018
Q4 | $10K | Buy |
2,384
+386
| +19% | +$1.62K | ﹤0.01% | 4635 |
|
|
2018
Q3 | $22K | Buy |
1,998
+954
| +91% | +$10.5K | ﹤0.01% | 4483 |
|
|
2018
Q2 | $17K | Buy |
+1,044
| New | +$17K | ﹤0.01% | 4458 |
|